{"paper_id":"b6c803dd-43ad-4dde-828e-371dd599d277","body_text":"HE4 is a novel tissue marker for therapy\nresponse and progestin resistance in\nmedium- and low-risk endometrial hyperplasia\nAnne Ørbo, Marit Arnes, Lena Myreng Lyså, Christer Borgfeldt and Bjørn Straume\nCorrection to: British Journal of Cancer (2016) 115, 725–730.\ndoi:10.1038/bjc.2016.247\nUpon publication of the above paper in the British Journal of\nCancer, the authors identified an error in the spelling of one of\ntheir names. The authors would like to apologise for this mistake.\nChrister Borgfeldt appears correctly in the author list above.\n& 2016 Cancer Research UK. All rights reserved 0007 – 0920/16\nCORRIGENDUM\nBritish Journal of Cancer (2016) 115, e15 | doi: 10.1038/bjc.2016.330\nwww.bjcancer.com | DOI:10.1038/bjc.2016.330 1","source_license":"CC0","license_restricted":false}